Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psoriasis comorbidities.
Guenther L, Gulliver W. Guenther L, et al. Among authors: gulliver w. J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S77-87. doi: 10.2310/7750.2009.00024. J Cutan Med Surg. 2009. PMID: 19799830 Review.
Incorporating biologics into the treatment of psoriasis.
Lui H, Langley R, Poulin Y, Gupta AK, Carey W, Guenther L, Searles G, Toole J, Lynde C, Gulliver W, Barber K. Lui H, et al. Among authors: gulliver w. J Cutan Med Surg. 2004 Aug;8 Suppl:8-13. doi: 10.1007/s10227-004-2003-6. J Cutan Med Surg. 2004. PMID: 15655584 Review. No abstract available.
The use of alefacept in the treatment of psoriasis.
Langley R, Gupta AK, Poulin Y, Guenther L, Barber K, Gulliver W, Lynde C. Langley R, et al. Among authors: gulliver w. J Cutan Med Surg. 2004 Aug;8 Suppl:14-8. doi: 10.1007/s10227-004-2004-5. J Cutan Med Surg. 2004. PMID: 15655585 Review. No abstract available.
Treatment decision needs of psoriasis patients: cross-sectional survey.
Tan J, Stacey D, Fung K, Barankin B, Bissonnette R, Gulliver W, Lui H, Shear N, Jackson C, Zhang X. Tan J, et al. Among authors: gulliver w. J Cutan Med Surg. 2010 Sep-Oct;14(5):233-9. doi: 10.2310/7750.2010.09049. J Cutan Med Surg. 2010. PMID: 20868620
Canadian hand dermatitis management guidelines.
Lynde C, Guenther L, Diepgen TL, Sasseville D, Poulin Y, Gulliver W, Agner T, Barber K, Bissonnette R, Ho V, Shear NH, Toole J. Lynde C, et al. Among authors: gulliver w. J Cutan Med Surg. 2010 Nov-Dec;14(6):267-84. doi: 10.2310/7750.2010.09094. J Cutan Med Surg. 2010. PMID: 21084020 Review.
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial.
Ritchlin C, Rahman P, Kavanaugh A, McInnes IB, Puig L, Li S, Wang Y, Shen YK, Doyle MK, Mendelsohn AM, Gottlieb AB; PSUMMIT 2 Study Group. Ritchlin C, et al. Ann Rheum Dis. 2014 Jun;73(6):990-9. doi: 10.1136/annrheumdis-2013-204655. Epub 2014 Jan 30. Ann Rheum Dis. 2014. PMID: 24482301 Free PMC article. Clinical Trial.
144 results